Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egido

Showing results (351-360 of 1,068) with videos related to

Pageof 107
Sort By:
Journal of Lipid Mediators|January 1, 1990
Cooperation between tumor necrosis factor (TNF) and platelet-activating factor (PAF) in the inflammatory responseC Maestre, P Zarco, C Gómez-Guerrero, et al.
Clinical Kidney Journal|June 12, 2015
Rituximab-associated interstitial lung disease in fibrillary glomerulonephritisValeria Sainz-Prestel, Jesus Hernandez-Perez, Jorge Rojas-Rivera, et al.
Cardiovascular Research|July 4, 2006
Biology of atherosclerotic plaques: what we are learning from proteomic analysisLuis Miguel Blanco-Colio, Jose Luis Martín-Ventura, Fernando Vivanco, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2012
The anthelmintic triclabendazole and its metabolites inhibit the membrane transporter ABCG2/BCRPBorja Barrera, Jon A Otero, Estefanía Egido, et al.
Journal of the American College of Cardiology|April 6, 2004
Decreased circulating Fas ligand in patients with familial combined hyperlipidemia or carotid atherosclerosis: normalization by atorvastatinLuis Miguel Blanco-Colio, Jose Luis Martín-Ventura, Josep M Sol, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 11, 2005
Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseasesMarta Ruiz-Ortega, Mónica Rupérez, Vanesa Esteban, et al.
Antioxidants & Redox Signaling|August 24, 2005
Long-term blood pressure control prevents oxidative renal injuryAlberto Lazaro, Julio Gallego-Delgado, Pilar Justo, et al.
Journal of the American College of Cardiology|May 8, 2010
Proteomic strategies in the search of new biomarkers in atherothrombosisJosé Tuñón, José Luis Martín-Ventura, Luis Miguel Blanco-Colio, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|January 22, 2017
Fast methods of fungal and bacterial identification. MALDI-TOF mass spectrometry, chromogenic mediaMaría Siller-Ruiz, Sara Hernández-Egido, Fernando Sánchez-Juanes, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1997
Endothelin-1 upregulation in the kidney of uninephrectomized spontaneously hypertensive rats and its modification by the angiotensin-converting enzyme inhibitor quinaprilR Largo, D Gómez-Garre, X H Liu, et al.
Pageof 107

Showing results (351-360 of 1,068) with videos related to

Sort By:
Pageof 107
Journal of Lipid Mediators|January 1, 1990
Cooperation between tumor necrosis factor (TNF) and platelet-activating factor (PAF) in the inflammatory responseC Maestre, P Zarco, C Gómez-Guerrero, et al.
Clinical Kidney Journal|June 12, 2015
Rituximab-associated interstitial lung disease in fibrillary glomerulonephritisValeria Sainz-Prestel, Jesus Hernandez-Perez, Jorge Rojas-Rivera, et al.
Cardiovascular Research|July 4, 2006
Biology of atherosclerotic plaques: what we are learning from proteomic analysisLuis Miguel Blanco-Colio, Jose Luis Martín-Ventura, Fernando Vivanco, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2012
The anthelmintic triclabendazole and its metabolites inhibit the membrane transporter ABCG2/BCRPBorja Barrera, Jon A Otero, Estefanía Egido, et al.
Journal of the American College of Cardiology|April 6, 2004
Decreased circulating Fas ligand in patients with familial combined hyperlipidemia or carotid atherosclerosis: normalization by atorvastatinLuis Miguel Blanco-Colio, Jose Luis Martín-Ventura, Josep M Sol, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 11, 2005
Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseasesMarta Ruiz-Ortega, Mónica Rupérez, Vanesa Esteban, et al.
Antioxidants & Redox Signaling|August 24, 2005
Long-term blood pressure control prevents oxidative renal injuryAlberto Lazaro, Julio Gallego-Delgado, Pilar Justo, et al.
Journal of the American College of Cardiology|May 8, 2010
Proteomic strategies in the search of new biomarkers in atherothrombosisJosé Tuñón, José Luis Martín-Ventura, Luis Miguel Blanco-Colio, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|January 22, 2017
Fast methods of fungal and bacterial identification. MALDI-TOF mass spectrometry, chromogenic mediaMaría Siller-Ruiz, Sara Hernández-Egido, Fernando Sánchez-Juanes, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1997
Endothelin-1 upregulation in the kidney of uninephrectomized spontaneously hypertensive rats and its modification by the angiotensin-converting enzyme inhibitor quinaprilR Largo, D Gómez-Garre, X H Liu, et al.
Pageof 107